Daré Bioscience (DARE) News Today $2.90 -0.12 (-3.97%) Closing price 03:59 PM EasternExtended Trading$2.92 +0.02 (+0.69%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Drug Development Is Slowing Down After Cuts at the FDAApril 17, 2025 | msn.comDare Bioscience to present on expanded business strategy at Jones ConferenceApril 8, 2025 | markets.businessinsider.comMaxim Group Keeps Their Hold Rating on Daré Bioscience (DARE)April 5, 2025 | markets.businessinsider.comQ4 2024 Dare Bioscience Inc Earnings CallApril 1, 2025 | finance.yahoo.comDaré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comDare Bioscience expects to start recording revenue, cash flow in Q425April 1, 2025 | markets.businessinsider.comDaré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compoundingMarch 31, 2025 | msn.comDaré Bioscience, Inc. (DARE) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comDaré Bioscience Reports Full Year 2024 Financial Results and Provides Company UpdateMarch 31, 2025 | globenewswire.comDare Bioscience Q4 2024 Earnings PreviewMarch 30, 2025 | msn.comA Look Ahead: Dare Bioscience's Earnings ForecastMarch 28, 2025 | benzinga.comDaré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025March 24, 2025 | globenewswire.comDaré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive ImplantFebruary 20, 2025 | finance.yahoo.comDare Bioscience risks Nasdaq delisting over market valueFebruary 14, 2025 | msn.comDare Bioscience secures additional NIAID funding for HPV treatmentFebruary 6, 2025 | msn.comDaré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV DevelopmentFebruary 6, 2025 | globenewswire.comDaré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | markets.businessinsider.comDaré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | globenewswire.comOptimistic Buy Rating for Daré Bioscience Driven by Strategic Progress and Financial PositionDecember 18, 2024 | markets.businessinsider.comDaré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)December 16, 2024 | markets.businessinsider.comDare Bioscience received payment of $2.5M under grant agreementDecember 5, 2024 | markets.businessinsider.comDaré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1December 4, 2024 | finance.yahoo.comDaré Bioscience, Inc.: Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company UpdateNovember 16, 2024 | finanznachrichten.deDare Bioscience files to sell 2.75M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comQ3 2024 Dare Bioscience Inc Earnings CallNovember 16, 2024 | finance.yahoo.comMaxim Group Remains a Hold on Daré Bioscience (DARE)November 16, 2024 | markets.businessinsider.comDare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...November 15, 2024 | uk.finance.yahoo.comDaré Bioscience: Advancing Women’s Health InnovationsNovember 15, 2024 | markets.businessinsider.comDaré Bioscience, Inc. (DARE) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comDaré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company UpdateNovember 14, 2024 | globenewswire.comInsights into Dare Bioscience's Upcoming EarningsNovember 14, 2024 | benzinga.comDare Bioscience Q3 2024 Earnings PreviewNovember 14, 2024 | msn.comDaré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024November 7, 2024 | globenewswire.comDaré Bioscience Enhances Investor Engagement with New PresentationOctober 26, 2024 | markets.businessinsider.comDaré Bioscience Secures Funding for HPV TreatmentOctober 24, 2024 | markets.businessinsider.comDaré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s HealthOctober 24, 2024 | markets.businessinsider.comDaré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's HealthOctober 23, 2024 | globenewswire.comDaré Bioscience Secures $15M Funding through Stock AgreementOctober 22, 2024 | markets.businessinsider.comDare Bioscience announces common stock purchase agreement fo up to $15MOctober 22, 2024 | markets.businessinsider.comDaré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLCOctober 21, 2024 | globenewswire.comCam Akers Fantasy Hub: Week 6 Injury Update, Start ‘Em/Sit ‘Em Advice, Points Projections, and MoreOctober 12, 2024 | msn.comDare County votes to fund school meals programOctober 9, 2024 | news.yahoo.comDare County subpoenas are latest to demand records linked to NC budget spendingOctober 6, 2024 | msn.comWho’d dare open a theatre now? These fearless impresarios wouldSeptember 30, 2024 | yahoo.comBill Gates helped fund birth control microchip but didn't invent it | Fact checkSeptember 26, 2024 | usatoday.comAbi Daré on 'Queenie' and the Book That Made Her a Better WriterSeptember 25, 2024 | msn.comHouston Texans Turn to Cam Akers Amidst Running Back IssuesSeptember 21, 2024 | msn.comDare County authorities address TikTok video claiming threat to schoolsSeptember 16, 2024 | msn.comIs Dare Ogunbowale related to Arike Ogunbowale? Explaining familial connection between Texans RB and Wings starSeptember 15, 2024 | msn.comDARE program returns to Lenoir County SchoolsSeptember 13, 2024 | msn.com Get Daré Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address DARE Media Mentions By Week DARE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DARE News Sentiment▼0.000.69▲Average Medical News Sentiment DARE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DARE Articles This Week▼01▲DARE Articles Average Week Get Daré Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioHarvest Sciences News Entera Bio News MacroGenics News Contineum Therapeutics News Alpha Cognition News Zura Bio News Ventyx Biosciences News Zentalis Pharmaceuticals News Pliant Therapeutics News Virios Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DARE) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DARE Stock Free DARE Stock Alerts